focus
Previous article:
The cancer drug shortage isn’t new — and neither are the solutions
Next article: The FDA must approve intranasal treatments for anaphylaxis
Next article: The FDA must approve intranasal treatments for anaphylaxis
focus
hotspot
-
Goldman Sachs launches $650M fund for life science investments
2025-10-02 17:14 -
Ahead of JPM, here's who's profiting most in health care
2025-10-02 16:30 -
Morgan Health, with ambitious aims, wants you to know it’s still here
2025-10-02 16:09 -
Ahead of JPM, here's who's profiting most in health care
2025-10-02 15:24 -
Why psychiatrists like me stop taking insurance
2025-10-02 15:04 -
Antibiotic resistance and the global rise in human conflict
2025-10-02 14:46